Navigation Links
First Quarter 2008 Financial Results Announcement and Teleconference

PHILADELPHIA, April 16 /PRNewswire-FirstCall/ -- On Wednesday, April 23, 2008, GlaxoSmithKline plc will announce its first quarter financial results for the three months ended March 31, 2008. The announcement is scheduled to be released to the London Stock Exchange at approximately 7:00 am (ET) US and will be available on the website: shortly thereafter.

Following the announcement, JP Garnier, Chief Executive Officer and Julian Heslop, Chief Financial Officer, will hold a global teleconference for analysts and investors. You are invited to listen in to this presentation of the first quarter 2008 results. This teleconference will take place on:

Wednesday, April 23rd at 9:00 am ET

To participate in the teleconference please dial:

U.S. Toll Free Phone +1 877 491 0064

Please quote: GSK Q1 Results

A recording of the teleconference will be available from 1:00 pm ET on April 23rd (until April 30th) on:

U.S. Toll Free phone + 1 888 365 0240

Passcode: 792110

GSK will host a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 9:00 am ET, and can be accessed directly via the GlaxoSmithKline website: Slides will be available shortly before the teleconference on the GSK website.

An archived version of this webcast will be available from the corporate website at approximately 3:00 pm ET on the same day.

SOURCE GlaxoSmithKline plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
(Date:10/8/2015)... WAYNE, Pa. , Oct. 8, 2015  Clarkston ... announced the call for applications for the 2016 Clarkston ... in a life sciences related field of study, a ... the selected Clarkston Scholar will receive exposure to the ... participation in Pennsylvania Bio events over the course of ...
(Date:10/8/2015)... Oct. 8, 2015  Today, DuPont and Caribou ... genome editing, jointly announced a strategic alliance. As ... their respective patent portfolios, with DuPont receiving exclusive ... major row crops, and non-exclusive rights in other ... --> --> In addition, ...
(Date:10/8/2015)... , ... October 08, 2015 , ... Talon Innovations, a ... Aerospace and other technology-driven industries, announces that it is one of three finalists for ... Midsize Company.” On Thursday, September 25 Talon Innovations was recognized as a nominee ...
(Date:10/7/2015)... ... October 07, 2015 , ... Neil Riordan, PhD to ... Summit Tomorrow, October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. , Dr. ... cell therapy. , He is the Co-Founder and Chief Science Officer of ...
Breaking Biology Technology:
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ) a biopharmaceutical ... drugs in the,therapeutic areas of infection, cancer and respiratory ... Leaders Bank to increase,its line of credit from $4 ... of,maturity by 12 months to January 1, 2011. The ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ), a clinical-stage ... novel medicines in the areas of,hepatitis C and ... the third quarter ended September 30, 2008., ... of our hepatitis C,development programs," said Steve Worland ...
... CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech ... an abstract entitled "A Phase I,Study to ... Docetaxel in Patients with Advanced Malignancies" will ... Journal of Immunotherapy, the official,journal of the ...
Cached Biology Technology:
(Date:10/8/2015)... Oktober 2015 Die Track Group, ... des Bereiches Tracking, hat heute bekannt gegeben, ... Virginias (Department of Corrections – DOC) unterzeichnet ... alle Strafen geliefert werden, die der Behörde ... für den Amerikanischen Kontinent der Track Group. ...
(Date:10/7/2015)... 8, 2015 --> ... Cards (FPC) during third quarter 2015 amounted to around 960 ... 860 MSEK that was communicated 20 August 2015. ... delivery capacity and a continued growing demand for the company,s ... to be higher than during the third quarter. The revenue ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
Breaking Biology News(10 mins):
... 1990s, the protein STAT1 (Signal Transducer and Activator of ... passing signals across immune cells, ensuring that our bodies ... other pathogens. Animals without STAT1 are also prone to ... protection against malignant cells. The STAT1 protein is known ...
... screening shellfish for fungal toxins is important, say scientists. ... Society for Applied Microbiology (SfAM) journal, Letters in ... contamination by strains of Penicillium fungus, bivalve ... at much higher levels that are found in the ...
... in Hong Kong when the engine control thrusts seized up ... The potential culprit? Contaminated fuel. The probability of ... popular and as distribution and supply systems use the same ... A professor and student team at the University ...
Cached Biology News:
Mouse Serpin F1/PEDF MAb (Clone 199315)...
Mouse MMP-24 (MT5-MMP) MAb (Clone 143908)...
Rabbit polyclonal to HMGB1 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 3146 SwissProtID: P09429...
Pooled normal sreum with 0.1% sodium azide as preservative...
Biology Products: